AA

Ali Akbar Kolambil

Active Director Designated Partner DIN 08396800
DIN 08396800 First appointment Feb 2019 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2019
Shareholding value β€’β€’β€’β€’ Premium profile

About Ali Akbar Kolambil

Data last updated:

Ali Akbar Kolambil is a Designated Partner at Neesay Pharmaceuticals Limited Liability Partnership (since 2019). The company operates in Chemicals.

DIN 08396800
Primary Designation Designated Partner
Industry Chemicals
First Appointment 26 Feb 2019
Oldest Company Age 10 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner26 Feb 20192016Active

Board colleagues of Ali Akbar Kolambil

NameDINCompanyDesignation
Parambengal Anvar07562349Neesay Pharmaceuticals Limited Liability PartnershipDesignated Partner

Directorship timeline

Open interactive timeline →
Neesay Pharmaceuticals Limited Liability Partnership
Premium access

Shareholding and investment profile for Ali Akbar Kolambil

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ali Akbar Kolambil

Ali Akbar Kolambil currently holds 1 directorship: Neesay Pharmaceuticals Limited Liability Partnership (Designated Partner, since 26 Feb 2019).

Ali Akbar Kolambil was first appointed on 26 Feb 2019 as Designated Partner at Neesay Pharmaceuticals Limited Liability Partnership.

The current boards of Ali Akbar Kolambil's companies include Parambengal Anvar (Neesay Pharmaceuticals Limited Liability Partnership).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available